---
title: "Simvastatin - Familial type 3 hyperlipoproteinemia"
sidebar: mydoc_sidebar
permalink: db00641-mesh-d006952-1.html
toc: false 
---


Path ID: `DB00641_MESH_D006952_1`
{% include image.html url="images/db00641-mesh-d006952-1.png" file="db00641-mesh-d006952-1.png" alt="db00641-mesh-d006952-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D019821 | Simvastatin | Drug |
| UniProt:P04035 | HMG-CoA reductase | Protein |
| MESH:D001055 | Apolipoprotein B (apoB) | ChemicalSubstance |
| MESH:D006952 | Familial type 3 hyperlipoproteinemia | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Simvastatin | DECREASES ACTIVITY OF | Hmg-Coa Reductase |
| Hmg-Coa Reductase | DECREASES ABUNDANCE OF | Apolipoprotein B (Apob) |
| Apolipoprotein B (Apob) | CONTRIBUTES TO | Familial Type 3 Hyperlipoproteinemia |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00641#mechanismofaction](https://go.drugbank.com/drugs/DB00641#mechanismofaction)
  - [https://pubchem.ncbi.nlm.nih.gov/compound/Simvastatin](https://pubchem.ncbi.nlm.nih.gov/compound/Simvastatin)

Reference: 
  - [https://go.drugbank.com/drugs/DB00641#mechanismofaction](https://go.drugbank.com/drugs/DB00641#mechanismofaction)
  - [https://pubchem.ncbi.nlm.nih.gov/compound/Simvastatin](https://pubchem.ncbi.nlm.nih.gov/compound/Simvastatin)
